about
WNT4 deficiency--a clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome: a case reportIdentification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and müllerian duct abnormalities: a French collaborative studyOvaries and female phenotype in a girl with 46,XY karyotype and mutations in the CBX2 geneThe gut-adipose-liver axis in the metabolic syndromeDiiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiencyImproved glucose tolerance in mice receiving intraperitoneal transplantation of normal fat tissue.Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice.ASK1 (MAP3K5) is transcriptionally upregulated by E2F1 in adipose tissue in obesity, molecularly defining a human dys-metabolic obese phenotype.Inverse regulation of basal lipolysis in perigonadal and mesenteric fat depots in mice.Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability.Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.Interleukin-6 contributes to early fasting-induced free fatty acid mobilization in mice.Uninephrectomy augments the effects of high fat diet induced obesity on gene expression in mouse kidney.Opposing effects of reduced kidney mass on liver and skeletal muscle insulin sensitivity in obese mice.The Fas pathway is involved in pancreatic beta cell secretory function.Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance.Depot-specific differences in adipocyte insulin sensitivity in mice are diet- and function-dependent.A short bout of HFD promotes long-lasting hepatic lipid accumulation.Identification of a SIRT1 mutation in a family with type 1 diabetes.Induction of cytosolic phospholipase a2α is required for adipose neutrophil infiltration and hepatic insulin resistance early in the course of high-fat feeding.WNT4 and sex development.Fas (CD95) expression in myeloid cells promotes obesity‐induced muscle insulin resistance.Two Siblings with the Same Severe Form of 21-Hydroxylase Deficiency But Different Growth and Menstrual Cycle Patterns.Short-term HFD does not alter lipolytic function of adipocytes.Visceral fat and metabolic inflammation: the portal theory revisited.Iron metabolism in patients with Graves' hyperthyroidism.Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells.The Aldosterone/Renin Ratio as a Diagnostic Tool for the Diagnosis of Primary Hypoaldosteronism in Newborns and Infants.Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function.Basal lipolysis, not the degree of insulin resistance, differentiates large from small isolated adipocytes in high-fat fed mice.Fas activation in adipocytes impairs insulin-stimulated glucose uptake by reducing Akt.Interleukin-1beta may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation.The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation.Response of interleukin-6 during euglycaemic and hyperglycaemic exercise in patients with type 1 diabetes mellitus.Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet.10-day hyperlipidemic clamp in cats: effects on insulin sensitivity, inflammation, and glucose metabolism-related genes.Fas and FasL expression in human adipose tissue is related to obesity, insulin resistance, and type 2 diabetes.Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance.Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation.Improved glycemic control and lower frequency of severe hypoglycemia with insulin detemir; long-term experience in 105 children and adolescents with type 1 diabetes.
P50
Q24301957-717F1D1B-1AB2-42E3-8428-7CDACCD9A9DEQ24305984-185FC888-0AD3-45C9-98E6-9B3BA7F120ABQ24314841-3C03FE04-6625-4CB3-B0F0-F02994ED6E07Q26995575-46822837-433A-4599-A6BA-23A89AAAD595Q28275432-4ECC2151-7B89-45AF-9C24-23A7B22967AFQ33276557-729FA7D5-5895-4405-AD19-FB3A97FDEDCFQ33559605-26919CF0-8131-4F23-B220-72D152BBBB19Q33836018-A6D788B9-EC40-4F06-AD51-C2109E351530Q34046431-EC48D8B3-35D5-474D-89D0-980ED6F0A87CQ34558529-F4C82A99-6ABE-49BA-8F54-9DC1392958FCQ34857481-2DF124FC-B2F9-42D5-8CEC-B4B6B1C6A15DQ35138143-DEA6DEDB-C61E-43A0-A341-96765EA30447Q35205861-219AD57E-6F90-4235-B3D4-EA7090EA6D6AQ35344041-69DB7E75-8ABA-4177-ADA9-8730B51BBECBQ35669781-029FD966-5B81-4FB7-9792-86AA6D8D543AQ35780689-621BF786-B25B-46D6-89A1-D06EDE14661FQ36719133-4594016A-CB52-4428-A09A-39483C656A5BQ36812330-8B9509E2-6BA6-4A3B-8A44-3D47283FFF99Q37101840-005A1CC2-84BE-42E4-B74F-001D0DA80E97Q37110575-8350D99B-AE0F-477F-A2AE-EEBA8C3C08AFQ37318680-E0D11954-44B3-46EF-9464-6E5B584137C1Q37606420-0D9080CE-7B7B-40D1-8171-B0675CA4C903Q37672420-DE7E05FC-D953-4FE1-BA9E-FE427EB63C19Q37692528-5C09B3C2-8F99-4DC2-A69B-6663D0BDEA9FQ38056228-D49CC060-17D0-4F37-9809-FC86455111A3Q40073812-D03C8943-C731-4FEE-8201-17DF66FF7D13Q40434190-0A92EA34-2299-4EFE-843A-ABDA0A4EB9FBQ40945590-A64EDB1C-D0E7-43D2-A01F-FA0B2A78F84AQ41540107-37475F30-AF72-40FC-AECB-15E383C8B2E1Q42445781-C97832E1-7078-44BE-8657-79233E7382E5Q42820719-AC297F10-9C3A-4C83-B05A-FC9CF9D00C60Q42824221-1F6871ED-7FD6-4921-BA96-B9FA6FF40A00Q42828619-ADA67FC5-42FA-45E4-9223-612A05F5B59FQ43032881-4DE057FF-76B2-48BC-B0FD-C0BEE97C9A3AQ43091069-3F0C71C8-F2CF-4B83-A60A-D0A85D147F69Q43159517-FED6E275-66D9-40FA-82B7-9E2A0FB9EB8DQ45201630-B9363AAE-38A1-4EF2-90EA-A88EEF96F9A0Q46145371-E95D7AAB-D991-489B-AEE1-9BF15D06FE69Q46432085-CDCC0D7F-71C3-4ABE-A9AF-A462F829F670Q46709594-A054327A-6959-4AC9-8A22-8AA0F8AC5298
P50
description
researcher ORCID ID = 0000-0001-9067-4356
@en
wetenschapper
@nl
name
Daniel Konrad
@ast
Daniel Konrad
@en
Daniel Konrad
@es
Daniel Konrad
@nl
type
label
Daniel Konrad
@ast
Daniel Konrad
@en
Daniel Konrad
@es
Daniel Konrad
@nl
prefLabel
Daniel Konrad
@ast
Daniel Konrad
@en
Daniel Konrad
@es
Daniel Konrad
@nl
P106
P21
P2798
P31
P496
0000-0001-9067-4356